Volta Labs Unveils Breakthrough Products at AGBT 2026 to Transform Genomic Sequencing

Volta Labs' Major Innovations Spark Excitement at AGBT 2026

In an exciting reveal at the AGBT 2026 conference, Volta Labs showcased a bold lineup of product launches and strategic partnerships that are set to reshape the landscape of genomic sequencing. With the introduction of advanced platforms and collaborative efforts, the company is poised to become a leader in automated genomics, ensuring high-quality results with ease.

Expanding Automation with Roche

Volta Labs has enhanced its Callisto™ platform in collaboration with Roche through the AXELIOS 1 project. This partnership focuses on integrating the automated prep workflow into Callisto, which previously had DNA extraction capabilities. The goal is simple yet ambitious: to provide a comprehensive solution for next-generation sequencing, allowing labs to benefit from an automated library prep process from day one. This reflects Volta's commitment to making sequencing easier and more efficient for its customers.

Breakthroughs in Oncology with Hartwig Medical Foundation

At AGBT, Hartwig Medical Foundation presented their work utilizing Volta's Callisto platform for circulating-tumor DNA (ctDNA) analysis, crucial for longitudinal patient monitoring and treatment decisions in oncology. The presentation emphasized the automation of cfDNA workflows and showcased the successes achieved by optimizing these processes for high-throughput environments. Hartwig's work highlights how Callisto can facilitate advanced clinical-grade whole-genome sequencing, especially for complex sample types, underscoring its operational advantages.

Collaboration with Watchmaker Genomics

Expanding its reach, Volta Labs has also partnered with Watchmaker Genomics to launch the Callisto™ Complete Kit for DNA EF Library Prep. This automated kit simplifies the entire process of conducting PCR-free whole-genome sequencing, effectively reducing hands-on time and ensuring high reproducibility across varying input challenges. The introduction of this kit marks a significant leap forward, as it streamlines the workflow and eliminates unnecessary complexity, making top-tier WGS more accessible.

Proven Results from Leading Institutions

The impact of these innovations was evident at the Volta Labs Sponsor Suite, where top-tier institutions like UMC Utrecht and Hartwig Medical Foundation shared their success stories using the Callisto platform. Over the past year, these organizations reported remarkable improvements in consistency, reproducibility, and overall operational efficiency, further proving demanding workloads can be effectively managed with Callisto.

Bert Van der Zwaag, a laboratory specialist at UMC Utrecht, remarked, "Since partnering with Volta Labs, we’ve deployed Callisto into our diagnostics workflows, processing thousands of samples efficiently. The demand exceeded our initial capacity, highlighting the platform's exceptional reliability. We're now expanding our use of Callisto to include new protocols for ctDNA, aiming for seamless laboratory-wide standards."

The Future of Genomics: Apps-Based Innovations

Volta Labs is not resting on its laurels. At AGBT 2026, the company announced an ambitious pipeline of pre-developed applications designed to simplify genomics workflows. These innovations aim to eliminate repeated processes and significantly reduce costs. As Udayan Umapathi, CEO, stated, "The goal of sequencing innovation should be accessibility. We're pushing for an era where automated genomics with just a push of a button is the standard practice, rather than the exception."

About Volta Labs

Headquartered in Boston, Massachusetts, Volta Labs is at the forefront of revolutionizing sample preparation for genomic sequencing. By leveraging digital fluidics, modular workflows, and full automation in its Callisto platform, the company is making strides in providing high-quality, reproducible NGS library preparation for a variety of applications. With a clear vision and commitment to innovation, Volta Labs is set to leave a lasting mark on the genomics landscape.

For more information about Volta Labs and its groundbreaking solutions, feel free to explore their website.